CAMPs Wound Care Summit 2025
Kent Imaging is excited to have team members presenting at the 2025 CAMPs Wound Care Summit taking place in Fort Lauderdale February 28 to March 2.
CAMPs (Cellular, acellular and matrix-like products) can play a major role in the treatment of non-healing wounds. There has been a flurry of LCD activity around CAMPs and skin substitutes, although, implementation of the LCD has been delayed to apply to dates of service after 04/13/25.
This summit is bringing together wound care experts to:
Clarify for providers, patients and manufacturers, the next steps forward until the LCD has been implemented
Outline best practices for CAMPs in wound care
Don’t miss THE PRESENTATIONS FROM OUR TEAM
Jennie Feight
MS, CPC, CPMA, CPC-I
Senior Director, Health Policy
Presentation: The new LCDs: what are they and what do they mean for you?
Dr. Jeffrey Niezgoda
MD, MAPWC, FACHM, CHWS
Chief Medical Officer of Limb Preservation
Presentation: Complementary therapies for CAMPs
Direct and Protect: Informed Medical Decision Making with SnapshotNIR
Joint Presentation on Day 3 of the event - getting to grips with the new CAMPs landscape with an insightful 20 minute presentation and 10 minute Q&A.
poster presentation
Abstracts have been selected for the poster presentation at the Cellular, Acellular, Matrix-like Products (CAMPs) Summit, taking place from February 28 – March 2, 2025:
Clinical Assessment of a Novel Sharp Debridement Device for Biofilm Management in Chronic Non-Healing Wounds Andrew Rader DPM, Jeffrey Niezgoda MD, Francis Derk DPM, Martha Kelso NP, and Sandeep Gopalakrishnan PhD, Lee Rogers DPM
The Plantar-Palmar Index with Near Infrared Spectroscopy Replaces the Ankle-Brachial Index for Noninvasive Evaluation of Vascular Perfusion and Peripheral Arterial Disease Jonathan A. Niezgoda, MS1 / Francis Derk, DPM / Debarpan Das, MSc / Najratun N Pinky, PhD / Jeffrey A. Niezgoda, MD
Financial Assessment of a Novel Sharp Debridement Device Compared to Traditional Sharp Debridement Instrumentation for Biofilm Management in Chronic Non-Healing Wounds Andrew Rader DPM, Jeffrey Niezgoda MD, Francis Derk DPM, Martha Kelso NP, and Sandeep Gopalakrishnan PhD, Lee Rogers DPM
SnapshotNIR could help IMprove CAmps integration success
Dr. Amy Couch, MD (Wound Care Physician at Mercy Hyperbaric and Wound Care, Missouri) showing a patient with a posterior heel wound that has been debrided and a CAMP applied.
Part of responsible CAMPs utilization is adequate wound bed preparation.
Using SnapshotNIR can confirm that adequate debridement has been accomplished prior to application of a CAMP increasing the likelihood of successful integration.
SnapshotNIR images provide clinical value and risk reduction by streamlining documentation processes with photographic evidence of optimal clinical technique.
Enhancing the successful utilization of CAMPS will provide improved healing thereby decreasing clinic visits and the pain associated with repetitive debridement procedures, together improving patient satisfaction scores.
see how wound care experts are using snapshotnir for camps applications
Dr. Naz Wahab, MD, uses weekly Kerecis (cellular, acellular, matrix-like products, or CAMPs) applications on chronic wounds to achieve wound closure. Dr. Wahab utilized SnapshotNIR, a near-infrared spectroscopy (NIRS) imaging to ensure CAMPs adherence and wound bed tissue oxygenation increases throughout the duration of the treatment plan.
Oxyhemoglobin and deoxyhemoglobin trends can indicate if a wound bed is prepared through adequate debridement. Using the wound sizing feature and StO2 of the scanned area from SnapshotNIR, you can ensure the right size of CAMP is used and applied, reducing product waste. SnapshotNIR can identify angiogenesis after a CAMP application, confirming clinical judgement regarding wound prognosis.
Case example from Dr. Naz Wahab, MD, Wound Care expert
Learn more about how snapshotnir can help with camps for chronic wounds
Use SnapshotNIR to:
Identify if a CAMP successfully integrates into the wound bed
Document the wound size area and linear dimensions to help select the best size of tissue application, reducing potential product wastage
Track wound healing trends, and document wound response, with image reports easily added to the patient record
Increase patient adherence to CAMPs application schedule
Provide supporting medical necessity data
WE LOOK FORWARD TO MEETING YOU!
Need more information? Unable to attend the event and want to connect with a product expert? Fill out the form below.
About CAMPs Wound Care Summit
The 2025 Cellular, Acellular, and Matrix-like Products (CAMPs) Wound Care Summit, hosted by Journal of Wound Care, is an exclusive, three-day event to explore the data and clinical best practice on CAMPs. Learn from industry leaders about new innovations in wound care and the use of CAMPS in a variety of clinical case such as: hard-to-heal wounds, trauma and surgical wounds, OR applications.
About Kent Imaging
Kent Imaging, located in Calgary, Alberta, Canada, is a leading innovator in near-infrared tissue oxygenation imaging, which develops, manufactures, and markets medical technology that supports real-time decision-making in wound care, vascular and surgical subspecialties. Kent holds multiple patents in oxygen imaging technology and continues to provide innovative and advanced diagnostic imaging solutions to aid healthcare systems nationally and internationally. SnapshotNIR is supported by clinical evidence demonstrating its ability to help improve clinical decision-making in wound care and reduce healing time. Since receiving FDA and Health Canada clearance in 2017, the technology has been featured in several published articles and peer-reviewed posters. Applying the knowledge gained from clinical trials to patient care promotes consistency of treatment and optimal outcomes.